ornithine has been researched along with Brain Neoplasms in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (96.15) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (3.85) | 2.80 |
Authors | Studies |
---|---|
Cai, F; Chen, F; DeBerardinis, RJ; Gao, X; Ge, WP; He, F; Lin, H; Liu, W; Luo, B; Sun, W; Vu, HS; Xing, C; Xiong, N; Xu, H; Yao, DX; Yuan, Y; Zacharias, LG; Zhang, FC; Zhao, H | 1 |
Bjerkvig, R; Deen, DF; Linden, M; Marton, LJ; Oredsson, SM | 1 |
Deen, DF; Gray, JW; Marton, LJ; Oredsson, SM | 1 |
Deen, DF; Feuerstein, BG; Marton, LJ; Oredsson, SM; Rosenblum, ML; Tofilon, PJ | 1 |
Byrd, DJ; Csejtey, J; Levin, VA | 1 |
Deen, DF; Hung, DT; Marton, LJ; Shafer, RH | 1 |
Deen, DF; Marton, LJ; Oredsson, SM | 2 |
Alhonen-Hongisto, L; Deen, DF; Marton, LJ | 2 |
Deen, DF; Marton, LJ; Oredsson, SM; Sano, Y | 1 |
Alhonen-Hongisto, L; Deen, DF; Marton, LJ; Oredsson, SM; Pegg, AE | 1 |
Alhonen-Hongisto, L; Deen, DF; Hung, DT; Marton, LJ | 1 |
Gutin, PH; Wilson, CB | 1 |
Deen, DF; Marton, LJ; Seidenfeld, J | 1 |
Gray, JW; Marton, LJ; Seidenfeld, J | 1 |
Deen, DF; Hung, DT; Marton, LJ; Seidenfeld, J | 1 |
Hervatin, SJ; Koch-Weser, J; Levin, VA; Marton, LJ; McCann, PP; Sjoerdsma, A | 1 |
Marton, LJ | 1 |
Marton, LJ; Seidenfeld, J | 2 |
Amacher, AL; Bolton, RJ; Gatfield, PD | 1 |
Levin, VA | 1 |
Alhonen-Hongisto, L; Levin, VA; Marton, LJ | 1 |
Deen, DF; Feuerstein, BG; Marton, LJ | 1 |
Mundinger, F; Ostertag, C; Potthoff, PC | 1 |
1 review(s) available for ornithine and Brain Neoplasms
Article | Year |
---|---|
Chemotherapy of primary brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Eflornithine; Ependymoma; Fluorouracil; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methotrexate; Mitoguazone; Mitolactol; Neoplasm Recurrence, Local; Ornithine; Prednisone; Risk; Thioguanine; Vincristine | 1985 |
25 other study(ies) available for ornithine and Brain Neoplasms
Article | Year |
---|---|
Using arterial-venous analysis to characterize cancer metabolic consumption in patients.
Topics: Acetylcarnitine; Adult; Aged; Agmatine; Biomarkers, Tumor; Blood; Blood Chemical Analysis; Blood Glucose; Blood Vessels; Brain Neoplasms; Female; Glioma; Glucose; Glutamine; Glutarates; Humans; Isocitrate Dehydrogenase; Male; Metabolomics; Middle Aged; Ornithine; Putrescine; Uridine Monophosphate; Young Adult | 2020 |
Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Cell Cycle; Cell Line; Eflornithine; Kinetics; Neoplasms, Experimental; Ornithine; Rats | 1983 |
Decreased cytotoxicity of 1-beta-D-arabinofuranosylcytosine in 9L rat brain tumor cells pretreated with alpha-difluoromethylornithine in vitro.
Topics: Animals; Brain Neoplasms; Cell Cycle; Cell Survival; Cells, Cultured; Cytarabine; DNA; Drug Synergism; Eflornithine; Ornithine; Rats; Time Factors | 1983 |
Differential potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine in chloroethylnitrosourea-sensitive and -resistant 9L rat brain tumor cells in vitro.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Cell Line; Drug Resistance; Drug Synergism; Eflornithine; Ornithine; Polyamines; Rats; Sister Chromatid Exchange | 1983 |
Brain, CSF, and tumor pharmacokinetics of alpha-difluoromethylornithine in rats and dogs.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Cerebrospinal Fluid; Dogs; Eflornithine; Kinetics; Neoplasm Transplantation; Neoplasms, Experimental; Ornithine; Rats; Rats, Inbred F344; Tissue Distribution | 1983 |
Depletion of intracellular polyamines may alter DNA conformation in 9L rat brain tumor cells.
Topics: Animals; Brain Neoplasms; DNA, Neoplasm; Eflornithine; Molecular Conformation; Ornithine; Polyamines; Putrescine; Rats; Spermidine; Viscosity | 1983 |
Influence of polyamine depletion caused by alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on alkylation- and carbamoylation-induced cytotoxicity in 9L rat brain tumor cells in vitro.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carboxy-Lyases; Carmustine; Cell Line; Cell Survival; Drug Synergism; Eflornithine; Ethylnitrosourea; Lomustine; Methylnitrosourea; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines; Rats | 1983 |
Decreased cytotoxicity of aziridinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro.
Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cell Line; Cell Survival; Cyclohexenes; Eflornithine; Kinetics; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines; Rats | 1984 |
Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Cell Division; Cell Survival; Drug Therapy, Combination; Eflornithine; Ornithine; Polyamines; Rats | 1984 |
Time dependence of the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity caused by alpha-difluoromethylornithine-induced polyamine depletion in 9L rat brain tumor cells.
Topics: Animals; Brain Neoplasms; Carmustine; Cell Line; Drug Synergism; Eflornithine; Kinetics; Ornithine; Ornithine Decarboxylase Inhibitors; Putrescine; Rats; Spermidine | 1984 |
Possible factors in the potentiation of 1-(2-chloroethyl)-3-trans-4-methylcyclohexyl-1-nitrosourea cytotoxicity by alpha-difluoromethylornithine in 9L rat brain tumor cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line; Cell Survival; Drug Synergism; Eflornithine; Ornithine; Polyamines; Rats; Semustine; Time Factors; Tumor Stem Cell Assay | 1984 |
Decreased cell kill of vincristine and methotrexate against 9L rat brain tumor cells in vitro caused by alpha-difluoromethylornithine-induced polyamine depletion.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Division; Cell Line; Cell Survival; Eflornithine; Kinetics; Methotrexate; Mitotic Index; Ornithine; Polyamines; Rats; Vincristine | 1984 |
New therapeutic approaches for brain tumors.
Topics: Brachytherapy; Brain Neoplasms; Bromodeoxyuridine; Eflornithine; Humans; Hyperthermia, Induced; Iodine Radioisotopes; Mitoguazone; Ornithine; Polyamines | 1984 |
Depletion of intracellular polyamine content does not alter the survival of 9L rat brain tumour cells after X-irradiation.
Topics: Animals; Brain Neoplasms; Cell Line; Cell Survival; Cells, Cultured; DNA; DNA, Neoplasm; Eflornithine; Guanidines; Mitoguazone; Ornithine; Polyamines; Putrescine; Radiation Tolerance; Rats; Spermidine; Spermine; X-Rays | 1980 |
Depletion of 9L rat brain tumor cell polyamine content by treatment with D,L-alpha-difluoromethylornithine inhibits proliferation and the G1 to S transition.
Topics: Animals; Brain Neoplasms; Cell Division; Cell Line; Dose-Response Relationship, Drug; Eflornithine; Interphase; Ornithine; Polyamines; Putrescine; Rats; Spermidine; Spermine | 1981 |
Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
Topics: Animals; Brain Neoplasms; Carmustine; Cell Cycle; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Eflornithine; Glioma; Kinetics; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines; Putrescine; Rats | 1981 |
Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
Topics: Animals; Brain Neoplasms; Carmustine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Eflornithine; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Ornithine; Rats; Rats, Inbred F344; Time Factors | 1981 |
Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro.
Topics: Animals; Brain Neoplasms; Carboxy-Lyases; Cisplatin; DNA; Eflornithine; Neoplasms, Experimental; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines; Putrescine; Rats | 1982 |
An approach to the use of polyamine inhibitors for cancer therapy.
Topics: Animals; Antimetabolites, Antineoplastic; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Eflornithine; Neoplasms, Experimental; Ornithine; Polyamines; Rats | 1981 |
Effects of DL-alpha-methylornithine on proliferation and polyamine content of 9L rat brain tumor cells.
Topics: Animals; Brain Neoplasms; Carboxy-Lyases; Cell Division; Cells, Cultured; Neoplasms, Experimental; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines; Putrescine; Rats; Spermidine; Spermine | 1980 |
Depletion of intracellular putrescine and spermidine by alpha-difluromethylornithine does not inhibit proliferation of 9L rat brain tumor cells.
Topics: Animals; Brain Neoplasms; Carboxy-Lyases; Cell Division; Depression, Chemical; Dose-Response Relationship, Drug; Neoplasms, Experimental; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines; Putrescine; Rats; Spermidine; Spermine | 1979 |
Hyperammonemia (ornithinemia) presenting as a unilateral cerebral mass lesion.
Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Astrocytes; Brain Diseases; Brain Neoplasms; Carbamoyl-Phosphate Synthase (Ammonia); Cerebral Cortex; Child, Preschool; Diagnosis, Differential; Functional Laterality; Glioma; Humans; Male; Ornithine; Syndrome | 1976 |
Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line; Eflornithine; Guanidines; Kinetics; Mitochondria; Mitoguazone; Ornithine; Putrescine; Pyruvates; Pyruvic Acid; Rats; Spermidine; Temperature; Time Factors | 1985 |
Effects of dicyclohexylamine sulfate, a spermidine synthase inhibitor, in 9L rat brain tumor cells.
Topics: Animals; Brain Neoplasms; Carmustine; Cell Cycle; Cell Survival; Cyclohexylamines; Eflornithine; Mitoguazone; Ornithine; Polyamines; Putrescine; Rats; Spermidine Synthase; Transferases | 1985 |
[Clinical use of ornithine-8-vasopressin in addition to a local anesthetic in neurosurgery].
Topics: Adult; Analgesia; Anesthesia, General; Anesthetics, Local; Blood Pressure; Brain Diseases; Brain Neoplasms; Craniotomy; Epinephrine; Female; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Ornithine; Pallor; Parkinson Disease; Postoperative Complications; Pulse; Stereotaxic Techniques; Trephining; Vasoconstrictor Agents; Vasopressins; Wound Healing | 1971 |